Home
|Insights
|Antitrust & COVID-19 in the U.S.: Four Key Issues for Healthcare Providers

PDF Link

Antitrust & COVID-19 in the U.S.: Four Key Issues for Healthcare Providers

Publication | 05.01.20

Attachments

Download Attachment
Antitrust COVID 19 In The US Four Key Issues For Healthcare Providers

Contacts

Alexis J. Gilman
Partner
He/Him/His
- Washington, D.C.
  - D | +1.202.624.2570
YWdpbG1hbkBjcm93ZWxsLmNvbQ==

Insights

Publication | 01.09.25

A ‘no-duh’ verdict? The Outcome Of Penn State v. Vintage Brand Allows Brand Owners To Chillax A Bit More

Publication | 12.26.24
Efficiency v Flexibility – The Patent Prosecution Highway (PPH) Program’s Pros and Cons
Publication | 12.23.24
Small Business Administration Proposed Rule Would Enact Material Changes As Well As Promote Regulatory Uniformity Across Size And Status Programs – Part 1
Publication | 12.23.24
The Federal Circuit Defines The “Public Disclosure” Exception To Prior Art Under 35 U.S.C. § 102(b)(2)

View All Insights

Subscribe

to the latest insights from our team